68 results
8-K/A
EGRX
Eagle Pharmaceuticals Inc
22 Dec 23
Departure of Directors or Certain Officers
5:15pm
or Disability (as defined in the Plan), (ii) a Change in Control (as defined in the Plan) or (iii) Mr. Graves’s termination without Cause (as defined in the Plan
8-K/A
EX-10.1
EGRX
Eagle Pharmaceuticals Inc
22 Dec 23
Departure of Directors or Certain Officers
5:15pm
will accelerate vesting and exercisability in full upon your death or Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan
8-K
EX-10.1
tb22aek1yl3pzk1oxe
9 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
EX-10.1
sb72gjnxhs79lsg9ljq
2 Nov 22
Entry into a Material Definitive Agreement
5:49pm
8-K
EX-10.2
uze 8c80lm7wtu56i8
9 Aug 22
Eagle Pharmaceuticals Reports Second Quarter 2022 Results
8:26am
8-K
EX-2.2
6h8kmcg5z n6tvqu
28 Mar 22
Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc
6:04am